The Malaysian AIDS Council (MAC) was established in 1992 to serve as an umbrella organisation to support and coordinate the efforts of non-governmental and other organisations working on HIV/AIDS issues in Malaysia
In an effort to prevent the spread of HIV infection among People who
Inject Drugs (PWIDs), the Ministry of Health has embarked on ambitious
Harm Reduction Programmes with two key initiatives, Needle Syringe
Exchange Programmes (NSEP) and Methadone Maintenance Therapy (MMT).
HRI have created a set of sponsor opportunities which will create a
dedicated and carefully engineered platform for engagement, profiling,
as well as structured opportunities to deliver key messages to a target
audience, throughout the conference
Harm Reduction International is committed to ensuring the event provides and facilitates appropriate care for all delegates who may have special medical and healthcare needs - especially delegates who use, or have used, drugs or are living with HIV or hepatitis.
Chairs: Rick Lines, Harm Reduction International and Datuk Raj Karim, President of the Malaysian AIDS Council
Speakers: YB Datuk Seri Dr. S. Subramaniam, The Honourable Minister of Health Malaysia Anand Grover, former UN Special Rapporteur on the Right to Health Maria Phelan, Harm Reduction International Mahd Razali Bin Ayub, WARDU/ANPUD
Presentation of the Carol and Travis Jenkins Award Presentation of the International and National Rolleston Awards
This session will discuss the retreat of international donor support from harm reduction and the challenges of transitioning to sustainable national-level financing
Marijke Wijnroks, Chief of Staff, Global Fund to Fight AIDS, Tuberculosis and Malaria Lambert Grijns, Ambassador for Sexual and Reproductive Health and Rights & HIV/AIDS of the Netherlands Dr Sha’ari Ngadiman, Ministry of Health, Malaysia Pascal Tanguay, Law Enforcement and HIV/AIDS Network
This session brings together leading lawyers and human rights advocates to discuss current efforts to end the death penalty for drug offences in four key death penalty States: China, Indonesia, India and Malaysia
Tripti Tandon, Deputy Director, Lawyer’s Collective (India) Ricky Gunawan, Program Director, LBH Masyarakat (Indonesia) Dr Yingxi Bi, (China) Shamini Darshni, Executive Director, Amnesty International Malaysia
‘Treatment as prevention’ for hepatitis C: addressing the needs of people who inject drugs?
Magdalena Rose Harris; Albers, Eliot; Swan, Tracy
Hepatitis C prevention and convenience: why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment?
Suzanne Fraser; Rance, Jake; Treloar, Carla Impact of Opioid Substitution Therapy and Needle
Syringe Programmes on incidence of HCV: a systematic review and meta- analysis
Lucy Platt; Reed, Jennifer; Minozzi, Silvia; Vickerman, Peter; French, Clare; Hagan, Holly; Maher, Lisa; Jordan, Ashly; Hickman, Matthew
Screening of viral hepatitis among tuberculosis patients
Surendra Khadka; Bista, Bikram
Vyacheslav Kushakov (International HIV/AIDS Alliance, Ukraine)
In Ukraine, the HIV epidemic is increasingly affecting young people. There is evidence that a large proportion (65%) of all HIV infections among boys aged 15 to 19 are directly associated with injecting drug use. Yet HIV-related policies and existing harm reduction services consistently overlook the harm reduction needs of the youngest segments of drug using populations, those aged 10 to 18. Since there are significant differences between younger and older PWID, harm reduction services need to employ substantially different and targeted outreach strategies, service combinations and service delivery mechanisms in order to address the needs of young PWUD/ PWID.
During this dialogue space, we will present the first conscious effort to target young people who use drugs with essential harm reduction services in Ukraine. We will share models of harm reduction service delivery for young PWUD and advocacy tools for the scale up of interventions at the country level.
Bill Zule has been at the forefront of moves to understand the importance of blood volume in used injecting equipment as a potential driver of blood borne virus epidemics.
In this dialogue space session Bill will describe how his understanding of this issue has developed, the evidence for the differences in risk between injecting equipment types, and the next steps for translating this knowledge into practice and optimising its impact on HIV and HCV prevention. There will be an opportunity to explore the language used to describe injecting equipment, the issues that arise when discussing dead space with injecting drug users, and practical issues that might affect local implementation.
Speaker(s): Session 1 speakers: Monica Beg (UNODC) Ruth Birgin (INPUD)
Session 2 speakers: Judy Chang (WHRIN) Judy Mungai (INPUD) Zoe Dodd (South Riverdale Community Health Centre) Ruth Birgin (INPUD)
Description: 1. Launch of the UNODC Practical guide for service providers on gender-responsive HIV services for women who inject drugs.
Harm reduction programmes are often not sufficiently accessible to women who inject drugs and not able to respond to their specific needs.
The purpose of this new guide is to:
- assist harm reduction service providers to expand the access to services to women who inject drugs through appropriate gender-sensitive and gender- specific services
- support harm reduction service providers to address gender issues within existing services and/or develop gender specific services
- offer advice on setting targets for scale-up access to comprehensive HIV services and expand coverage
A working group consisting of the International Network of Women Who Use Drugs (INWUD), the Women and Harm Reduction International Network (WHRIN), and the Eurasian Harm Reduction Network (EHRN) provided oversight with UNODC in the development of the guide.
2. Women who Use Drugs as Activists and Advocates - the challenges and solutions (Interactive)
This session will discuss the particular challenges and barriers that women who use drugs face in the harm reduction and drug policy reform movement. Women who use drugs face double stigmatization and more oppressive social and ‘moral’ norms, often presenting barriers for engaging in advocacy. How can women who use drugs overcome these challenges, and create and maintain an active voice in drug policy reform and harm reduction movements?
Policies, programming and services remain weighted towards men, and are gender- blind. These critical gaps can be bridged, by ensuring the participation of women who use drugs. Currently the presence of women in drug policy, and harm reduction advocacy remains overshadowed by men. How can women who use drugs challenge the status quo in male-dominated spaces of harm reduction and drug policy reform? Further to this, are there opportunities to embrace the intersectionalities between gender and drug use, race and/or ethnicity, sexuality and trans movements?
This interactive session will explore these issues. Four women who use drugs will discuss their personal experiences and provide a sound basis for discussion and debate on the synergies for future action.
Place of harm reduction and rehabilitation programmes in work with underage drug users
The social context of non- medical prescription opioid use among young adults: a qualitative study
Jesse L.Yedinak; Kinnard, Elizabeth N.; Hadland, Scott E.; Green, Traci C.; Clark, Melissa A.; Marshall, Brandon D.L.
‘We don’t need services. We have no problems’: exploring the experiences of young people who inject drugs in accessing harm reduction services
Anita Krug; Hildebrand, Mikaela
‘Intravention’: young drug injectors’ leadership in promoting health-protective behaviours among their peers
Pedro Mateu-Gelabert; Guarino, Honoria; Jessell, Lauren; Syckes, Cassandra; Friedman, Samuel R.
Facilitator(s): Seyed Ramin Radfar (Thought, Culture and Health Institute)
This workshop will explore the various methamphetamine harm reduction experiences around the world, including the development, implementation and results of a pilot methamphetamine harm reduction programme in Iran. The objectives of the workshop are to:
1. Understand the epidemiology of methamphetamine
2. Identify the differences and similarities of methamphetamine harm reduction and opioid harm reduction activities
3. Learn about one of the very few experiences in the world regarding methamphetamine harm reduction integration into regular harm reduction services
Format: Short presentations, group work and plenary discussion. Participants will be asked to break into small groups to discuss and share their findings on the similarities and differences between methamphetamine and opioid- related harms and harm reduction services. Evaluation of the workshop will be undertaken through short pre- and post-tests.
Facilitator(s): Hang Lai (Supporting Community Development Initiatives) Sarah Evans (Open Society Foundations) Kailin See (Drug User Resource Centre)
Description: Objective: Harm reduction to date has largely focused on opiate injection. However, the use of smoked stimulants (amphetamines, cocaine, and derivatives like crack and basuco) is increasing in many localities. Smoked stimulant use is associated with risky sex and other drug use, HIV, Hep C, and mental health issues. At the same time, the very fact that stimulant users are not (yet) injecting drugs means that timely harm reduction programming is critical and the opportunities many. In reality, however, few effective, evidence-based interventions exist for stimulant users (and data is sorely lacking).
The default response in many parts of the world is a police crackdown on users, followed by compulsory ‘treatment’ or jail – even when no obvious crime has been committed or the user does not want or need treatment. Today, the biggest contributor to injury and death among stimulant users is violence connected to the drug market, and at the hands of police. Community-based programmes struggle to connect with stimulant users, whose needs and behaviors seem different from those of people who use opiates. Harm reduction tools for stimulants users (sterile crack smoking kits, supervised inhalation sites) are often an afterthought to methadone and needle and syringe programmes, and remain controversial long after programmes for people who use opiates have been accepted.
Format: Using short presentations, group activities, and plenary discussion, three dynamic facilitators from around the world will share strategies and approaches for including stimulant users in harm reduction programming.
Speaker(s): Adrian Gschwend (Swiss Federal Office of Public Health)
René Akeret (Member of Swiss Federal Expert Commission on drugs)
Historically, harm reduction has been heroin-focused and driven by concern over the risks of injecting. However, drug use, including type of drugs used, patterns of use, and profiles of risk behavior, are typically evolving rather rapidly. According to EMCDDA data, in many Western European countries, heroin use has steadily declined since 2007. Concomitantly, heroin injecting appears to have decreased and use by other routes, notably inhalation and to a lesser extend sniffing, has become more and more popular. Further, new phenomena challenge the traditionally opiate-focused drug policies:
- Excessive recreational substance abuse, especially in nightlife
- Poly drug use, especially in combination with alcohol
- New psychoactive substances (NPS), designer drugs, “legal highs”
- Psychoactive pharmaceuticals, neuroenhancers, “brain doping”
During this dialogue space we will explore the potential of harm reduction for addressing such new patterns of drug use. The focus is thus shifted away from survival-oriented interventions to safer use and reduction of health / social risks for recreational substance users. We will discuss these issues by introducing practices of harm reduction in the context of nightlife interventions in Switzerland. Participants of this dialogue space will discuss the extension of the harm reduction concept to the emerging trends in drug use drawing from experiences in their own countries.
Speaker(s): Rui Miguel Coimbra Morais (CASO, INPUD, EuroNPUD)
This dialogue will space will explore decriminalisation from the perspective of people who use drugs, illuminating both the benefits and the much less discussed problems. It will discuss outcomes in relation to stigmatisation and discrimination; the ambiguous effect of being medicalised; access to rights; and the opportunities for our community to be meaningfully involved in all aspects of our lives.
Crystal methamphetamine use among gay and bisexual men in Australia: patterns of use and harm reduction responses
Toby Lea; Hopwood, Max; Ryan, Dermot; Wright, Shannon; Holt, Martin; Aggleton, Peter
Men Who Have Sex with Men in a highly stigmatizing environment: the case of greater Cairo, Egypt
Sherif Mohamed Said Elkamhawi; Abaza, Oumnia; Khoury, Carla; Tawakol, Ghazal; Abdel Malak, Maryham; El-Beih, Wessam; Youssef, Hala; El-Kott, Nabeel; Sanan, Nehad; El-Kha
Perceptions and experiences of injecting novel psychoactive substances in sexual settings among gay men in London
Adam Bourne; Reid, David; Weatherburn, Peter; Torres-Rueda, Sergio
Using peer education to work with lesbian, gay, bisexual and transgender (LGBT) drug users in NSW
Shannon Wright; Ryan, Dermot; Parkhill, Nicolas
Harm reduction saves and improves lives: Findings of Increased quality-of-life for people who inject drugs in the Hridaya impact assessment study in selected Indian states
Visvanathan Arumugam; Biswas, Kaushik; Sharma, G Charanjit; Beddoe, Simon W; Mehta, Sonal; Peters, Tim; Robertson, James
Do different types of heroin produce different risks for developing abscesses and other skin and soft tissue infections?
Dan Ciccarone; Unick, Jay; Mars, Sarah; Rosenblum, Dan
Conceptualizing the hospital ‘risk environment’ for people who use drugs: challenges and potential solutions
Lianping Ti; Milloy, M-J; Buxton, Jane; McNeil, Ryan; Dobrer, Sabina; Hayashi, Kanna; Wood, Evan; Kerr, Thomas
Longitudinal analysis of individual harm reduction coverage in an Australian cohort of people who inject drugs
Daniel John O’Keefe; Aitken, Campbell; Dietze, Paul Mark
This session will focus on improving access to viral hepatitis B and C treatment in people who use drugs.
It will introduce the new WHO guidelines on HBV and HCV screening, care and treatment with specific focus on people who use drugs as well as the WHO global strategy and regional action plans on viral hepatitis and particular relevance for people who use drugs. Several key experts from a range of constituencies will respond and comment on the recommendations, their perspectives and experiences. The focus of this discussion is on critical issues and ways to address challenges with regard to providing hepatitis treatment to people who use drugs.
Introduction on WHO guidance and strategies - Nick Walsh
Civil society perspective:
Treatment Action Group - Karyn Kaplan
ANPUD - Anand Chabungbam
International HIV/AIDS Alliance in Ukraine-
MSF - Leena Menghaney
The Global Fund - Mauro Guarinieri Open
Society Foundations – Daniel Wolfe
This session is supported by the World Health Organization
The challenges of outreach workers in the implementation of the Needle and Syringe Exchange programme in Malaysia
Azlinda Azman;Karunanithy, Anushiya; Baba, Ismail; Ellan, Parimelazhagan; Sivapragasam, Malini
Increasing syringe exchange 1,5 times in 4 years within the same budget? Evidence from Eastern Europe, Latvia
No one wants to use the dirties: people who inject drugs reflect upon re-use practices
Angella Duvnjak; Morrison, Ele
Experience from an interactive educational pilot programme aiming at behavioural changes among injecting drug users in Paris from 2011 to 2014: impact on risk practices and lessons learned
Elisabeth Avril; Debrus, Marie; Rogissart, Valère; Maguet, Olivier; Corty, Jean- François
Facilitator(s): Jude Byrne (Australian Injecting & Illicit Drug Users League) Jay Levy (INPUD)
This workshop--geared to anyone in a care or support role (including peer workers) and to managers--will orient participants to a new international tool for carers working with people who use drugs and other key populations. Carers face difficult decisions. The tool will help carers in community-based organisations make more ethical decisions when faced with competing choices or when the rights or interests of two people (perhaps parent and child) are in conflict.
With proper guidance, carers can make more ethical decisions, ones not influenced by stigma about who has the ability or right to parent. Facilitators will share results from a global survey of care workers and their clients. Building on real-life ethical dilemmas, facilitators will then guide participants in the use of the guidance, including the four step tool that is at its heart, to develop understanding of how ethical decision-making differs from following the law, organisational policy, religion, culture or societal norms.
Facilitator(s): Katrin Schiffer (Correlation Network)
New Psychoactive Substances (NPS) are no longer limited to people experimenting with drugs. NPS use is increasing in populations of People who Use Drugs Heavily (PUDH). Social, health and harm reduction services across Europe are unprepared for the emerging use of NPS and lack the capacity and the tools to address this issue in an effective way. Capacity building and training is needed to increase the knowledge-base among professionals, peers and PUDH is needed to develop effective harm reduction strategies in this field.
The workshop will provide an overview on the situation on NPS in general and describe the policy responses to the increasing use of NPS in Europe. The main part of the workshop will address challenges and potential approaches, which have been implemented in various European countries. The input is based on the interventions in 5 European countries. The implemented RAR methodology and the experiences will be shared and discussed with the participants.
In the last part of the session, we will address the increasing role of the internet and describe and discuss potential online interventions.
The Guide to Employing People who Use Drugs in Harm Reduction was produced for the International HIV/AIDS Alliance Community Action on Harm Reduction. It draws on the experience of CAHR partners and also other harm reduction organisations that have pioneered the employment of PWUD. The Guide gathers together experience and learning into a comprehensive resource for harm reduction services. It is designed to support managers and staff alike, to make their organisations welcoming and supportive workspaces for PWUD. The Guide recognises the important and valuable contribution that PWUD can make to harm reduction services. It also identifies human resources and personal development strategies that can help staff who use drugs to perform to their highest potential. The Guide recognises the additional challenges that PWUD may face in working in a context of discrimination and criminalisation and it identifies practical ways that organisations can support their staff and manage problems.
Mat Southwell, the Guide’s author, will introduce and launch the Guide. Charan Sharma will describe his experience working for the Alliance India as a manager who uses drugs and draw out lessons. Three case studies of staff who use drugs will be discussed in small groups, helping people to practice using the Guide as a technical resource. The session will conclude with questions, discussion and answers. The session is presented by CoAct and the Alliance CAHR programme.
Speaker(s): Pierre de Vasson (Independent consultant in supply chain for harm reduction supplies)
The Harm Reduction Supplies Knowledge Hub, a non profit, independent hub run by harm reductionists, proposes a website to break the lack of access to information related to evidence-based articles, selecting, quantifying, sourcing and the procurement of harm reduction products. It aims to offer necessary information to improve procurement and list international publications to guide all steps of the products’ supply chain, from the science behind it to waste management. We would like your feedback to improve this innovative idea.
The Global Commission on Drug Policy has constantly called for the removal of the legal or de-facto barriers to harm reduction services, and the implementation of the package of comprehensive interventions developed and recommended by the WHO, UNODC and UNAIDS.
Moreover, this package has been strengthened by WHO’s consolidated guidelines for key populations, in particular underlining the need to address structural barriers in order to implement effective and accessible programmes. Now that the UNGASS is approaching, it is time to re-evaluate the commitment of a horizontal UN approach to the world drug problem and harm reduction.
This session will aim at discussing the role of the international community and the UN agencies in scaling- up harm reduction services and taking advantage of the UNGASS to discuss the social, economic, medical and development benefits of harm reduction and of a whole UN comprehensive approach to drugs.
Michel Kazatchkine, Global Commission on Drug Policy
Edmund Settle, United Nations Development Program
Monica Beg, United Nations Office on Drugs and Crime
Annette Verster, World Health Organization
TBC, Joint United Nations Programme on HIV/AIDS
Organizers: Global Commission on Drug Policy, United Nations Development Programme, World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS
Speaker(s): Pascal Tanguay (Law Enforcement and HIV/AIDS Network)
Law enforcement practices can disrupt harm reduction programmes and contribute to the risk environment in which PWUD live. It is possible for harm reduction services to establish relations with law enforcement on local and national levels that reduce harm from criminalisation and help law enforcement contribute to an enabling environment for health and rights promotion. In 2015, UNODC released a guide for CSOs on improving working relationships with police. The session will present some of the key ideas presented in the guide and open up for discussion around the audience’s experience of cooperation between harm reduction services and law enforcement, including what measures civil society can implement to reduce negative encounters with law enforcement.
Speaker(s): Dr. Popava Elena Lvovna (Assistant Chief Doctor of Government Narcological Dispenser Tashkent, Uzbekistan)
During this session, Dr. Popava will discuss the experience and positive results of a one year trial undertaken in Tashkent, Uzbekistan, on the use of Naltrexone in preventing relapses among people who wish to stop using opiate-based drugs. Following the presentation, the floor will be opened for discussion.
Speaker(s): Anita Krug (Youth RISE) Jeffry Acaba (Youth LEAD) Sandeep Shahi (YKAP Nepal) Alya Jannata (PKNI) Government representative/service provider (TBC)
This interactive session will explore some of the major issues affecting young people who inject drugs in the Asia Pacific and discuss examples of good practice in youth engagement and the development and implementation of youth-friendly services. This session is targeted at harm reductionists, researchers, UN representatives and harm reduction advocates.
Developing networks for people/ women who use drugs in East Africa: Tanzania and Kenya
Putting it into practice: providing integrated sexual and reproductive health (SRH), HIV and harm reduction services for women who use drugs in Mombasa, Kenya
Lilian Kayaro Esemere; Maloti, Danson Mwawana; McCartney, Daniel Jason
Research on access for women who inject drugs to HIV prevention, treatment and care services in Kazakhstan, Kyrgyzstan and Tajikistan
Towards establishing successful (peer-led) gender-sensitive services for women who use drugs
Parina Subba Limbu; Bradbury, Gill;
Community mobilisation and organising
Mick Webb; Masanja, Susan
Harm reduction advocacy initiative in Japan: drug users and the stakeholders raised their voices for human rights and public health
Advocacy platforms for PWID: establishing state drug user forums under the Asia Action on Harm Reduction programme in India
Simon Wallington-Beddoe; Imlong, Tushimenla; Arumugum, Viswanathan; Sharma, Charanjit; Mehta, Sonal; Robertson, James
NY harm reduction educators UPRISE peer programme. A path to empowerment, employment, and social justice
Mike Selick; Jones, Terrell
‘The Connection’ an aboriginal and Torres Strait Islander drug user service
Aimee Maree Capper
Overdose prevention services upon release from prison
Parallels between HIV and HCV epidemics among young injectors in two countries: New York City, USA and Medellin, Colombia
Pedro Mateu-Gelabert; Dedsy Berbesi, Honoria Guarino, Stephanie Campos, Shana Harris, Lauren Jessell, Samuel R. Friedman
Broadening the map of psychoactive substances: the universe of drugs v.2.0
Médecins du Monde (MdM) challenges sofosbuvir’s patent in Europe to improve universal access to HCV treatment
Celine Grillon; Tahir Amin, Jean-François Corty, Chloé Forette, Gaelle Krikorian, Marie-Dominique Pauti, Priti Radhakrishnan, Lionel Vial, Olivier Maguet
When bulk isn’t best - the benefits of single use packs for the injection of street drugs
Carole Hunter; John Campbell
Exploring the decision to not inject: Policy implications for harm reduction strategies aimed at non-injection drug users
Andrew Kristofer Ivsins; Cecilia Benoit, Susan Boyd, Karen Kobayashi
Characteristics of male injecting drug users in Greater Cairo, Egypt
Oumnia Abaza; Sherif Elkamhawi, Mariham Abdel Malak, Carla Khoury, Ghazel Tawakol, Wessam Elbeih, Hala Youssef, Hisham Ramy, Nehad Sanan, Ehab Elkharrat, Nabil Elkott, Cherif Soliman
Levels of mortality among people who inject drugs from causes other than AIDS
Mathers Bradley; Louisa Degenhardt
Facilitator(s): Benjamin Phillips (Harm Reduction Coalition) Alissa Sadler (Open Society Foundations) Zara Snapp (Global Commission on Drug Policy) Robin Beck (Stop the Harm) Edward Fox (Release)
With the 2016 United Nations General Assembly Special Session (UNGASS) on drugs fast approaching, and reform happening apace across Latin America and the U.S., global drug policy has entered into a dynamic and critical era. UNGASS presents an unprecedented opportunity to engage and mobilise a global audience to advance harm reduction and drug policy reform. Yet, selling harm reduction and drug policy reform has never been an easy task. This workshop aims to make it easier by providing participants with the resources and knowledge to join and tailor the global ‘Stop the Harm’ campaign to locally relevant audiences and issues. Moreover, it seeks to lay foundational work for coalition and campaign building, and communications skills development that can be utilised to build momentum beyond UNGASS.
The objective of this workshop is to introduce participants to the core principles and online platform of the Stop the Harm campaign before providing them with the tools, knowledge, skills, and confidence to engage, disseminate, and tailor Stop the Harm to promote their work for local audiences. Realistic and strategic UNGASS ‘asks’ and thematic areas will be reviewed, and key moments for mobilisation will be identified.
The workshop format: Using short presentations, practical examples, and group discussion, five dynamic facilitators will work closely with participants to examine the core themes of the Stop the Harm campaign, and their direct application to the particular local issues relevant to participants. The facilitators—experienced campaigners and communications experts—will share strategies and approaches to tackling participants’ specific campaign goals and objectives in the lead up to UNGASS and beyond.
Facilitator(s): Facilitators: John Hamilton, (CEO, Recovery Network of Programs) Khuat Thi Hai Oanh, (ED, Center for Supporting Community Development Initiatives, Vietnam)
Presenters: Thomas Cai (AIDS Care, China) Pascal Tanguay (Law Enforcement and HIV/AIDS Network) Olivier Maguet (Médecins du Monde) Machteld Busz, (Mainline) John Hamilton, (Recovery Network of Programs) Peter Higgs, (National Drug Research Institute)
The objectives of this workshop are to (1) generate ideas for voluntary and effective services for drug users, and (2) create an opportunity for making connections between people with experiences of providing voluntary services to drug users with people who are working to develop such a system.
This workshop is targeted at a mixture of people with experiences in countries with good programmes for people who use drugs and people who are working in countries that still have compulsory drug treatment centers, including government officials, policy makers, NGOs and community representatives.
Speaker(s): Anita Krug (Youth RISE) Bikash Gurung (Youth RISE) Maria Phelan (HRI) Damon Barrett (International Centre on Human Rights and Drug Policy) Sylvia Ayon (KANCO)
An international working group has developed a tool which offers guidance to help organisations prepare for work with children. Step by Step: Preparing for Work with Children who Inject Drugs takes organisations through exercises that help staff think about the critical issues of child rights and protection, evolving capacities of young people and how to balance conflicting ethical and legal issues. The tool helps staff recognise the overlapping vulnerabilities of young drug users and builds knowledge in organisations on how to respond. The tool has been developed and piloted with harm reduction service providers.
This session will discuss the outcomes from a recent consultation conducted by INPUD with the community of people who inject drugs in several regional, and one global consultation, in relation to their thoughts on PrEP. It is a thought provoking paper giving much needed insight into the priorities and pressing issues for people who inject. It offers a much needed corrective to the uncritical hype that is being widely given to this biomedical “magic bullet”.
Models of service delivery of the comprehensive package for people who use and inject drugs
Annette Verster; Rodolph, Michelle; Rachel, Baggaley
Decentralisation and integration facilitates earlier access to HIV services
Nguyen Thi Minh Tam; Duc Duong, Bui; Thi Thuy Van, Nguyen; Kato, Masaya
Harm reduction against the odds! The Afghanistan experience
Dr Feda Mohammad Paikan; Rajaey, Abdur Raheem; Rahimi, Dr.Mohammad Hashim; Southwell,Mat
‘Ya pas Drap’: starting harm reduction services in Abidjan - Ivory Coast after the results of a rapid assessment and response
Jérôme Evanno; Bailly, Cynthia; Dézé, Charlotte; Luhmann, Niklas; Bouscaillou, JUlie; Maguet, Olivier
This session is supported by the World Health Organization
Transitions to injecting heroin in Kenya: research findings, community perspectives and implications for programming
Maryna Braga; Guise, Andy; Ndimbii, James; Dimova, Margarita; Mar Han, Zin; Ochera, John; O. Cawstone, Anthony; Nyakundi, James; Kimami, John; Mureithi, John; Apuuli
Injection of morphine sulphate capsules among drug users in Paris, France, and specific related risks: what do we need to adapt in our harm reduction interventions?
Marie Debrus; Avril, Elisabeth; Rogissart, Valère; Maguet, Olivier; Corty, Jean-François
Insights into injecting into the neck and risk from a national sample of people who inject drugs in the United Kingdom
Lisa Maher; Cullen, Katelyn J; Hope, Vivian D; Ncube, Fortune; Parry, John V
West African pattern for drug, set and setting. Consequences on local harm reduction interventions and regional networking
Olivier Maguet; Dembele, Bintou; Ba, Idrissa; Evann, Jérôme; Olivet, Fabrice; Mahjoubi, Bilel
Drugs, Dignity and Dying: developing palliative care guidelines for methadone maintenance patients in Ireland
Juliet Homan Bressan; Flanagan, Jean; Madani, Anjum
‘Doctors punish us using detox’. To explore the range of problems that clients opioid substitution treatment (OST) have experienced with doctors- narcologists in Eastern Europe and Central Asia
Barriers to Optimal Implementation of Methadone Maintenance Therapy in Bangkok, Thailand: a qualitative study
Kanna Hayashi; Ti, Lianping; Small, Will; Pramoj Na Ayutthaya, Prempreeda; Kaplan, Karyn; Suwannawong, Paisan; Kerr, Thomas
Assessment of methadone substitution treatment social and economic effectiveness in the Republic of Belarus
Efforts in support for transition from CCDU to voluntary community-based treatment and services in Asia
Olivier Lermet; Vladanka Andreeva,
Everything on my own: gaps in services for women who use drugs in Malaysia
Fifa Rahman; Sarah Iqbal, Priya Lall, B Vicknasingam
Accreditation of opioid substitution therapy centres in India: ensuring quality services
Sophia Khumukcham; Neeraj Dhingra, Kim Hauzel, Chin Samte, Abraham Lincoln
Evaluating the prescriber dosing trends of opioid substitution treatment program in private medical practitioner clinics after the implementation of psychotropic permit in Malaysia
Dzafarullah Daud; Mohd Bokhari Md Noor, Bahirah Borhan, Mohd Nazri Md Dazli
Country recommendations for creating enabling legal environments for access to HIV services for people who use drugs in Asia
Brianna Harrison; Edmund Settle
Sentencing Harm Reduction in Kachin State, Myanmar. Need for action
Olivier Maguet; Renaud Cachia, Thomas Dusouchet
UNDP is scaling up medication assisted therapy (MAT) with methadone in prisons of Kyrgyzstan
Peer driven intervention reaches hard to reach populations of people who inject drugs (PWID) in China
Zhihua, Yan Cai; Thomas; Luo, Tina; Braga, Maryna; Smyrnov, Pavlo; Kushakov, Slava
Facilitator(s): Louisa Gilbert (Global Health Research Center of Central Asia) Olga Rychkova (Open Society Foundations) Irena Ermolaeva (Asteria)
Description: Workshop Objective: This workshop will provide an overview of the WINGS intervention, a gender-based violence (GBV) screening, brief intervention and referral model developed specifically to address the critical and intersecting needs of women who use drugs and experience GBV. GBV is a human rights violation and a serious public health concern among women who use drugs. Exposure to violence significantly increases risk of HIV infection, but often remains unaddressed due to lack of resources, capacity and awareness among HIV, harm reduction, and anti-violence programmes. WINGS was developed to address this service gap and was piloted in New York and Kyrgyzstan. The model focuses on identifying links between drug use and violence and includes GBV screening, risk assessment, safety planning, goal setting and social support to address GBV, referrals to GBV-related services and gender-specific HIV counseling and testing. In Kyrgyzstan, the WINGS pilot identified extremely high rates of GBV among women who use drugs: 80.8% reported experiencing either physical or sexual intimate partner violence in the prior year. The WINGS pilot demonstrated promising results in reducing GBV incidents, as well as decreasing drug use and increasing access to GBV and HIV services.
Workshop format: The workshop will provide an overview of the WINGS intervention, highlight structural, community and organisational factors that may facilitate or impede its implementation, and provide an opportunity to discuss challenges and lessons learned. Participants will be asked to break down into small groups to identify strategies to adapt and implement WINGS to their programme settings.
Facilitator(s): Adam Bourne (London School of Hygiene & Tropical Medicine), Andy Guise (University of California, San Diego), Eliot Albers (INPUD) Claudia Stoicescu (Harm Reduction International), Edo Agustian and Rima Ameilia (Indonesian Drug Users Network)
If evidence is to be collected and utilised in a meaningful and ethical way, it is essential that key populations are the centre of research activities. Community based research (CBR) is an approach to engaging at-risk populations in the design, collection and dissemination of data so that the resulting findings can best meet their needs. The session will begin by considering the various meanings and approaches to community based research. There are many different models of conducting research that is led by the community, or ensures their meaningful involvement, which can be effective in different settings or in addressing different research questions. A panel of speakers from community organisations, NGOs and universities will share their experience of leading or participating in research studies across a range of high, middle and low income settings. The experiences they describe will span a range research methods and will consider both the successes and challenges of adopting a community based approach. Within the workshop, delegates will be asked to consider what might constitute key principles of meaningful involvement in research for people who inject drugs. What are the essential characteristics that make a research project ‘community based’ and what are the values that both academic and community researchers should ascribe to that help ensure we deliver high quality, ethical research? We hope to establish a network of individuals interested in developing and promoting principles of community based research as a standard approach for all research with, by and for people who use drugs.
The purpose of this dialogue space is to explore what it is that binds us together. We now have three decades of experience of harm reduction across a wide-range of disciplines, socio-political contexts and cultures. Some of us have been here from the beginning; others will be in their early days. Some will have made a specific personal or professional decision to take up the mantle of harm reduction; others will have come to harm reduction through circuitous circumstance, happenstance or chance. Some will have accepted the approach immediately; others will have needed convincing. Ultimately, most bring unbridled passion and commitment to the cause of harm reduction, be they advocates, practitioners, researchers, or policy- makers. This diversity of experience and history is what we wish to capture. Participants will be asked a simple question: “Describe the moment that made you realise that harm reduction was the way forward and what that meant for you?” All will be invited to participate, with a two-minute limit per contribution. Time will be allocated at the end for guided discussion and reflection. The session will be filmed and contributions (with permission) will be uploaded to the conference website.
This session will explore key areas of tension within the current drug control regime as we head towards the 2016 UN General Assembly Special Session on Drugs
Chairs: Mme Ruth Dreifuss and Kasia Malinowska-Sempruch
Dr Carl Hart, Columbia University Prof Juan E Mendez, UN Special Rapporteur on Torture Prof Adeeba Kamarulzaman, Dean of Medicine, University of Malaya Annie Madden, Executive Officer, Australian Injecting & Illicit Drug Users League (AIVL)
Speaker(s): Carla Treloar (Centre for Social Research in Health) Magdalena Harris (London School of Hygiene and Tropical Medicine)
This collection of papers explores the clear challenges in achieving optimal prevention and care of hepatitis C among people who inject drugs. With papers from researchers, clinicians and community advocates, this collection canvasses the most pressing issues, explores strategies to address hepatitis C infection and emphasises the need for partnership with communities affected by hepatitis C. It is hoped that this collection provides important information to help move this agenda forward, while stimulating discussion for achieving global control of hepatitis C and substantially reduce the global burden of hepatitis C -related disease. This collection was a collaboration between International Journal of Drug Policy and the International Network of Hepatitis in Substance Users.
A study on violation of the rights of PWUD in drug de-addiction and rehabilitation centres in Manipur, India
Advocacy for a drug policy based on harm reduction and respect of the human rights of PWID in Morocco. A working synergy between NGOs and national bodies in the fight against AIDs and human rights
Moulay Ahmed Douraidi; Karkouri, Mehdi; Ahmar, Morgane; Himmich, Hakima
Addressing stigma and discrimination targeted at people who inject drugs - a multifaceted approach
Fiona Poeder; Pepolim, Lucy; Harison, Tiia; Harrod, Mary
The impact of the Indonesian government’s ‘emergency drugs’ declaration on harm reduction outreach programmes in south of Jakarta
Andika Prayudi Wibaskara
Co-chair: Ana Lúcia Ferraz (Ministry of Health, Brazil)
This session examines and highlights crack and other stimulant use in Latin America, and the harm reduction response.
Sponsored by the Ministry of Health of the Government of Brazil, it will showcase research from the region, as well as examples of successful low threshold harm reduction services
Myrez Cavalcanti (Braços Abertos Program)
- São Paulo programme for people who use crack
Francisco Netto, Fiocruz– the Crack Report in Brazil
Ricardo Baruch, Espolea, Mexico – Drug use and LGBT people: study on meth in Mexico
Carola Lew, UNODC - the Crack Report in Uruguay
Leadership in transition: Ministry of Health Malaysia initiated government – non government organisation (GO-NGO) partnership, the driving force behind success of harm reduction efforts in Malaysia
Shamala Chandrasekaran; Ellan, Parimelazhagan; Kurusamy, Tamayanty; Suleiman, Anita
Peer leadership within Nepal’s community based harm reduction organisations: processes of community organising, systemic barriers to advocacy and countering the abstinence-based recovery agenda
Ashmin Thapa; Nicolette, Burrows
Effects of take-home methadone service on treatment compliance and heroin use reduction for methadone maintenance treatment clients
Zhihua Yan; Cai, Thomas; Zhang, Bo; Chen, Suoyu
Situation of injection drug use related HIV epidemic and response in Pakistan: planning for post 2015 era
Anne Bergenstrom; Achakzai, Baseer; Furqan, Sofia; Saba, Marc;
Speaker(s): Jean-Francois Martinbault (Sandy Hill Community Health Centre)
The purpose of this dialogue space is to illustrate that housing is the best way to empower people who use drugs to make healthier choices. It will demonstrate the effectiveness of the Housing First Approach as a harm reduction strategy. Focusing on housing allows us to see drug users as people with dreams, goals, hobbies, skills and personalities; instead of only focusing on their drug use. The dialogue space will give participants the concrete tools needed to implement a Housing First Intervention in their communities.
The Housing First Intervention from the Oasis Program, in Ottawa, Canada, will serve as a foundation for discussion and information sharing. The participants will then have an opportunity to actively engage in a discussion about the model, to identify concrete problems and solutions that are applicable to their own experiences and environments. The group’s expertise will be used to problem solve and find relevant results.
Speaker(s): Khine Thazin Soe (Burnet Institute, Myanmar)
There are approximately 75,000 PWID in Myanmar. The city of Mandalay is situated in the centre of the country and at the confluence of major drug trafficking routes. The city consequently shoulders a great burden of the drug use. This session will discuss the implementation and positive results of a 6-month programme in which peer-led rapid testing for HIV was successfully delivered in Mandalay. Within a short period of time this service proved to be a safe space for PWID to undertake HIV testing, helping to reach the UNAIDS targets of 90-90-90. In order to achieve these ambitious targets PWID must not be left behind.
Speaker(s): Mat Southwell (CoAct) Charan Sharma (Alliance)
Peer based needle exchange exists in many different forms from secondary needle exchange to peer outreach teams to supplier based schemes to needle and syringe programmes (NSP) run as part of drug user organisations. The global community is recognising the potential to end the AIDS epidemic, however, this will only be possible if HIV prevention measures can be deployed at scale with people who inject drugs (PWID). For NSPs to reach out into the injecting drug using community, peers need to be engaged or supported to promote the exchange of injecting equipment and adoption of safer injecting practices.
This session will champion peer based NSPs as part of a comprehensive HIV response that is highly adaptable to local conditions and when delivered at scale can significantly impact on HIV and Viral Hepatitis among PWID. This session is another step in technical support collaboration between CoAct, the International HIV/AIDS Alliance Community Action on Harm Reduction programme and the UK National Needle Exchange Forum. Through different events and an online practice sharing project, different peer NSP projects have shared their resources and experiences. CoAct has also produced a series of videos documenting examples of peer based NSP with injectingadvice.com. This Dialogue Space is a chance to gather learning and experiences on Peer NSP. Mat Southwell from CoAct will share key lessons of the project to date. Charan Sharma will then discuss the work of Alliance India in promoting different models of peer NSP as part of the CAHR programme. Everyone is welcome but if you have experience of Peer NSP then please bring resources (ideally in electronic format) that can be shared as part of this open source practice development project. CoAct will also be shooting videos to document examples of Peer NSP.
This session presents practical insights, benefits and challenges of cooperation between law enforcement, public, social and health authorities and CSO. Speakers will explore the potential and limitations of different schemes of cooperation while bringing into focus the specifics of practical implementation
Svetlana Doltu; Country Coordinator of Police and HIV network, Lieutenant Colonel (retired), Ministry of Interior, Republic of Moldova
Identifying and reducing harm for steroid and image enhancing drugs (SIEDs) injectors, through innovative approaches
John Campbell; Hunter, Carole
The harm reduction response to an increase in people who inject performance and image-enhancing drugs attending needle and syringe programmes in Australia: a tale of two states
Jenny Iversen; Maher, Lisa
Risk and vulnerability among people who inject image and performance enhancing drugs in England and Wales 2012-2013: where should we focus harm reduction?
Katelyn J Cullen; Hope, Vivian D; Parry, John V; Ncube, Fortune
An unhealthy glow? A review of Melanotan use and associated clinical outcomes
Rebekah Lynne Brennan; Wells, John; Van Hout, Marie Claire
Description: Issue: Merely providing sterile injection materials, general information, education and communication (IEC) to intravenous drug users has been shown to have a limited impact on several injection-related diseases: most importantly the hepatitis C virus (HCV), and other viral and bacterial infections. This workshop targets people who inject drugs (PWID) and harm reduction workers.
Workshop objective: The aim of this workshop is to improve knowledge on the wide scope of risk behaviours associated with drug injection-related practices and to provide educational and teaching techniques in order to involve PWIDs in less at-risk injection practices.
Workshop format: After a short presentation of the issue, we will present our French experiences and explain our teaching techniques and the tools used:
- Anatomical plastic-arm with veins to improve injection skills
- Visual risk-scale to work on the risk-perception of beneficiaries
- Colouring agent to show the HCV transmission within injection related paraphernalia
- Route transition intervention (RTI) tools
- Additional methods to find veins
The participants will be divided in different groups to test our tools. The last part of the session will be focused on sharing participant experiences.
For 23 years, Liz Evans worked in a community under siege from the impact of criminalising and pushing away people who use drugs. She was a young nurse who witnessed first hand how the impact of policies intended to help were causing destruction and crippling her community. Making progress required a complete reversal in thinking and in policy, from all angles. Her community mobilised, and used public education efforts, political advocacy and direct action to stimulate change. The results were radical. A demilitarised zone in the war on drugs was formed; a state within a state for those not accepted or seen as less than human in mainstream society. They formed a network of housing, specialised health care approaches including North America’s supervised injection site, managed alcohol programmes, crack pipe vending machines, a bank, shops, a laundry, a dental clinic, and hundreds of opportunities each month for community members to engage in paid and volunteer activities. Abstinence was not a requirement for citizenship and these spaces shifted the discourse about what is possible.
During this dialogue space, Liz will share this story to show how talking about harm reduction does not go nearly far enough for societal transformation to happen. There is a need to fight for marginalised drug users to be treated with dignity across systems while shining the light on the human cost of our policy failures.
Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean …
Anand Grover, is a designated Senior Advocate, practicing in the Supreme Court of India and the Director of the Lawyer’s Collective (India), having offices in Mumbai, Delhi and Bangalore. He was the UN Special Rapporteur on the right of everyone …
Annie Madden is the Executive Officer of the Australian Injecting & Illicit Drug Users League (AIVL) the national organisation representing people who inject or have injected illicit drugs including people in drug treatment in Australia. Annie …
Carl Hart is an Associate Professor at Columbia University in the Departments of Psychiatry and Psychology. He is also a Research Scientist at the New York State Psychiatric Institute and has published nearly 100 scientific articles in the area of …
Marijke Wijnroks joined the Global Fund to fight AIDS, Tuberculosis and Malaria as its Chief of Staff on 15 July 2013. In her position she has a broad responsibility and a particular focus on gender and human rights and on engaging with all …
Lambert Grijns is Director of the Social Development Department and Special Ambassador for Sexual and Reproductive Health and Rights (SRHR) & HIV/AIDS at the Ministry of Foreign Affairs of the Netherlands. He is a member of the High-Level Task …
Liz Evans trained as a nurse, and in one of Canada’s poorest postal codes worked for 23 years to envision and create numerous services that changed the way drug users are seen and treated. People who were previously dying from overdose deaths …
Lynn M. Paltrow, J.D., is the Founder and Executive Director of National Advocates for Pregnant Women (NAPW). Ms. Paltrow is a graduate of Cornell University and New York University School of Law. As Executive Director of NAPW, Ms. Paltrow …
Mariângela Simão - Director, Rights, Gender, Prevention and Community Mobilization Department, UNAIDS. Mariângela Simão joined UNAIDS in July 2010 from the Ministry of Health in Brazil where she worked since 2006 as the Director of the …
UN Secretary-General’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia Professor Michel Kazatchkine has spent the last 30 years fighting AIDS as a leading physician, researcher, administrator, advocate, policymaker, and diplomat. …
With almost 15 years of experience in the field of HIV and Drug Use from the grassroots level where it is about saving one life at a time to the global boardrooms where public health policies and programs are made to stand against corporate greed …
Ricky Gunawan is an Indonesian human rights lawyer and the Director of the Community Legal Aid Institute (LBH Masyarakat), based in Jakarta. He earned his law degree from the University of Indonesia. He holds MA in Theory and Practice of Human …
Ruth Dreifuss studied in Geneva where she received a degree in economics with special focus on econometrics in 1971. In her varied professional career she served as hotel secretary, editor of the weekly journal Coopération, social worker, …
Shamini began her career as a news journalist at the New Straits Times covering current issues. She found her beat writing health and social issues, with a particular interest in HIV and AIDS issues. Nearly 7 years later, she moved on to the …
Tripti Tandon is a New Delhi based lawyer and Deputy Director with the Lawyers Collective, one of the oldest human rights organisation in India. In her over 15 years of association with the Lawyers Collective, Tripti has spearheaded the work …
Yingxi Bi is a Senior Research Associate at the International Centre on Human Rights and Drug Policy. Ms Bi obtained her PhD recently in the Irish Centre for Human Rights, at the National University of Ireland, Galway. Her recent work focuses on …